Law360, New York (July 08, 2011, 4:47 PM ET) -- The Federal Circuit on Friday ruled that two Respironics Inc. patents for sleep apnea treatments were invalid as anticipated by prior art, reversing a lower court and handing a victory to accused infringer Invacare Corp.
Overturning a Pennsylvania federal court's decision, the appeals court held that Invacare had demonstrated that Respironics' patents were anticipated by a 1987 article penned by respiratory therapy specialist Magdy Younes.
On remand from an earlier appeal, the district court had concluded Invacare had not shown that the article disclosed all the...
Fed. Circ. Finds Respironics' Apnea Patents Invalid
To view the full article, take a free trial now.
